The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Large-scale land acquisition on behalf of real estate company
Represented a real estate company in the investment purchase of approximately 5,100 acres of undeveloped land in coastal South Carolina. more
Covad Communications v. BellSouth Corporation (antitrust litigation in Atlanta federal district court)
Served as lead in-house counsel representing BellSouth in this significant antitrust case, which raised issues under essential facilities doctrine more
Merger of a major Georgia vision care retailer
Conducted due diligence review of labor and employment issues, with an emphasis on wage and hour issues under federal and state law, for a major more
Priority of other insurance coverage for death and bodily injury following a refinery explosion
After the trial court ruled on summary judgment that Citgo, as an "additional insured" under our client’s GLC policy, could obtain $5 million in more